Auriane Leblond
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Auriane Leblond has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Denis Séraphin
University of Angers, SONAS, SFR QUASAV, F-49000 Angers, France
1 shared publication - Emilie Roger
MINT, Inserm, CNRS, SFR ICAT, CHU Angers, University of Angers, Institut Universitaire de France (IUF), F-49000 Angers, France
1 shared publication - Franck Bastide
Institut Agro, University Angers, INRAE, IRHS, SFR 4207 QuaSaV, F-49000 – Angers, France
1 shared publication - Guillaume Viault
SONAS, SFR QUASAV, University of Angers, F-49000 Angers, France
1 shared publication - Jean-Jacques Helesbeux
SONAS, SFR QUASAV, Université Angers, F-49000 Angers, France
1 shared publication - Marc Litaudon
Institut de Chimie des Substances Naturelles, CNRS, UPR 2301, Université Paris-Saclay, 91198 Gif-Sur-Yvette, France
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 714
Identification of Antioxidant Plant Extracts and Garcinia amplexicaulis Metabolites with Ferroptosis Inhibitor-like Chemical Properties for Alternative Crop Protection
Background: Sustainable strategies to control fungal diseases are urgently needed due to the environmental and human health impacts of conventional fungicides and the rise in fungicide resistance. Ferroptosis modulation, an iron-dependent programmed cell death, could represent an alternative strategy for crop protection, although its potential for fungal disease management remains largely unexplored. Methods: The aim of this study was to run preliminary screening assays, identify plant extracts and natural products with requested chemical properties for ferroptosis inhibition, and evaluate their ability to limit Alternaria brassicicola infection. Results: The CAT-based screening of 165 plant extracts led to the identification of several antioxidant-active extracts, including Garcinia amplexicaulis (G. amplexicaulis) (bark, DCM), Garcinia kola (G. kola) (nut, DCM), Magnolia sieboldii (M. sieboldii) (leaf, MeOH) and G. amplexicaulis (leaf, MeOH). The major constituents, δ-amplexichromanol, δ-garcinoic acid, sieboldin and (−)-epicatechin, found in the most active fractions from these extracts displayed CAT activities comparable to those of the synthetic ferroptosis inhibitors ferrostatin-1 and phenoxazine. Among these compounds, δ-amplexichromanol showed detectable in vitro inhibitory activity against A. brassicicola and significantly reduced lesion development in planta, with an efficacy comparable to ferrostatin-1 and phenoxazine. The antifungal activity of G. amplexicaulis (leaf, MeOH) observed in vitro was also confirmed in planta. Conclusions: these findings highlighted δ-amplexichromanol and G. amplexicaulis (leaf, MeOH) as candidates for further investigation and supported the potential of CAT-based antioxidant screening to prioritize plant extracts for subsequent evaluation against A. brassicicola.
- 25 September 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 714
Open AccessIdentification of Antioxidant Plant Extracts and Garcinia amplexicaulis Metabolites with Ferroptosis Inhibitor-like Chemical Properties for Alternative Crop Protection
Background: Sustainable strategies to control fungal diseases are urgently needed due to the environmental and human health impacts of conventional fungicides and the rise in fungicide resistance. Ferroptosis modulation, an iron-dependent programmed cell death, could represent an alternative strategy for crop protection, although its potential for fungal disease management remains largely unexplored. Methods: The aim of this study was to run preliminary screening assays, identify plant extracts and natural products with requested chemical properties for ferroptosis inhibition, and evaluate their ability to limit Alternaria brassicicola infection. Results: The CAT-based screening of 165 plant extracts led to the identification of several antioxidant-active extracts, including Garcinia amplexicaulis (G. amplexicaulis) (bark, DCM), Garcinia kola (G. kola) (nut, DCM), Magnolia sieboldii (M. sieboldii) (leaf, MeOH) and G. amplexicaulis (leaf, MeOH). The major constituents, δ-amplexichromanol, δ-garcinoic acid, sieboldin and (−)-epicatechin, found in the most active fractions from these extracts displayed CAT activities comparable to those of the synthetic ferroptosis inhibitors ferrostatin-1 and phenoxazine. Among these compounds, δ-amplexichromanol showed detectable in vitro inhibitory activity against A. brassicicola and significantly reduced lesion development in planta, with an efficacy comparable to ferrostatin-1 and phenoxazine. The antifungal activity of G. amplexicaulis (leaf, MeOH) observed in vitro was also confirmed in planta. Conclusions: these findings highlighted δ-amplexichromanol and G. amplexicaulis (leaf, MeOH) as candidates for further investigation and supported the potential of CAT-based antioxidant screening to prioritize plant extracts for subsequent evaluation against A. brassicicola.